HLA and it Relation With the Development of Proliferative Diabetic Retinopathy in Mexican Population

Phase 3

Withdrawn

• Conditions: Diabetes Mellitus Type 2; Proliferative Diabetic Retinopathy

• Registration Number: NCT00600236
• Lead Sponsor: Asociación para Evitar la Ceguera en México

Brief Summary

One of the first causes of irreversible blindness in mexican population is diabetic retinopathy which is clearly diferent between patients the time of evolution and development of retinopathy and complications. The aim of this study is to explore the inmunogenetic profile and the influence of HLA in this variations of the sickness to predict the severity of diabetic complications.

Detailed Description

Not available

Study Timeline

• Study Start: 2004-09
• Study First Submitted: 2006-06-30
• Primary Completion: 2008-01
• Study Completion: 2008-01
• Study First Submitted QC: 2008-01-23
• Study First Posted: 2008-01-24
• Status Verified: 2024-05
• Last Update Submitted: 2024-05-31
• Last Update Posted: 2024-06-03

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Diabetes mellitus type 2 with 10 years of diagnosis and no diabetic retinopathy
• Diabetes mellitus type 2 with 10 years of diagnosis and proliferative retinopathy

Exclusion Criteria

• Systemic hipertension
• Cardic disease
• Lupus
• Any kind of artritis
• Allergies
• Optic Neuritis
• VKH
• Cancer
• Inmunological diseases

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Trial Locations

Locations (1)

Asociación para Evitar la Ceguera en México, Hospital "Luis Sanchez Bulnes"; 🇲🇽 Mexico City, Mexico DF, Mexico